ABSTRACT
Cutaneous lymphoma (CL) in most cases is in the end stage of a stepwise pathogenetic process that originates from a reactive inflammatory chronic stimulation of lymphocytes and dendritic cells. Through the accumulation of mutations in genes that regulate the cell cycle, in oncogenes and in suppressor genes, this inflammatory process transforms into malignant lymphoma.
